ASTM E1053; Antiviral Claim Verification

ASTM E1053: Antiviral Claim Verification for Surface Microbicides

Airmid Healthgroup provides independent, GLP-compliant ASTM E1053 testing services — evaluating the virucidal efficacy of liquid, aerosol, foam, and trigger-spray microbicide products intended for use on inanimate, non-porous environmental surfaces. Our ISO/IEC 17025-accredited laboratory delivers the independently validated antiviral data needed for EPA and FDA regulatory submissions and third-party product claims.

The Standard for Virucidal Surface Disinfectant Validation in the US Market

ASTM E1053 is the primary ASTM standard used to assess the virucidal activity of products on hard, non-porous surfaces. It is widely referenced by the US EPA and FDA for antiviral product registration and claim substantiation — making it an essential test for manufacturers entering or expanding in the North American market.

Scope of ASTM E1053

ASTM E1053 is used to evaluate the virucidal efficacy of liquid, aerosol, or trigger-spray microbicides intended for use on inanimate, non-porous environmental surfaces. The method may be employed with most viruses that can be grown in cultured cells, though other host systems — such as embryonic eggs — may be used with proper justification and documentation.

This test method may be used to determine the effectiveness of liquid, aerosol/foam, and trigger-spray products against designated prototype viruses. The number of lots of the test substance and the number of replicates in each test will depend on the requirements of the target regulatory agency.

Certain regulatory agencies may require additional testing using other carrier tests for product registration purposes.

Key Scope Requirements

Product Types Covered

Liquid disinfectants, aerosols, foams, and trigger-spray products intended for use on inanimate, non-porous environmental surfaces.

Virus Flexibility

The method can be employed with most viruses that can be grown in cultured cells — allowing testing against the specific viral targets most relevant to your product’s claims and intended market.

GLP Requirements

Testing must follow GLP regulations where applicable — 40 CFR Part 160 for EPA submissions and 21 CFR Part 58 for FDA submissions. Airmid conducts all ASTM E1053 testing in full GLP compliance.

Biosafety Requirements

This test method should only be performed by those trained in microbiological and virological techniques in facilities equipped for work with infectious agents at the appropriate biosafety level — as provided by Airmid’s BSL-2 virology laboratory.

ASTM E1053 Testing Protocol

Test Standard
ASTM E1053 — Standard Practice to Assess Virucidal Activity of Chemicals Intended for Disinfection of Inanimate, Nonporous Environmental Surfaces
Product Types
Liquid disinfectants, aerosols, foams, trigger-spray products
Test Organisms
Viruses grown in cultured cells — specific strains selected based on product claims and regulatory requirements
Regulatory Alignment
EPA (40 CFR Part 160) and FDA (21 CFR Part 58) GLP requirements
Turnaround Time
Contact our team for a project-specific timeline based on the virus strains and test conditions required

Why Choose Airmid Healthgroup for ASTM E1053 Testing?

BSL-2 Virology Laboratory

Our purpose-built biosafety level 2 virology laboratory is equipped and staffed for safe handling of the infectious agents required for ASTM E1053 testing.

EPA & FDA GLP Compliance

All testing is conducted in accordance with 40 CFR Part 160 (EPA GLP) and 21 CFR Part 58 (FDA GLP) — producing data suitable for US regulatory submissions.

ISO/IEC 17025 Accredited

Our laboratory holds ISO/IEC 17025:2017 accreditation from the Irish National Accreditation Board (INAB, Reg. No. 284T) — ensuring results meet the highest international standards of accuracy and reproducibility.

Flexible Virus Selection

We work with manufacturers to select the most appropriate test viruses for their product’s intended claims and target regulatory agency — including Influenza A, Human coronavirus, RSV, and others.

Request a Quote for ASTM E1053 Testing

Contact Airmid Healthgroup to discuss your antiviral surface disinfectant testing requirements and receive a tailored quote for ASTM E1053 testing.

Get in Touch

Frequently Asked Questions

What is ASTM E1053 used for?

ASTM E1053 is used to evaluate the virucidal efficacy of liquid, aerosol, foam, and trigger-spray disinfectant products on inanimate, non-porous surfaces. It is the primary ASTM standard for antiviral surface disinfectant claim substantiation and is widely accepted by the US EPA and FDA for product registration purposes.

Which viruses can be used in ASTM E1053 testing?

The method can be employed with most viruses that can be grown in cultured cells. Commonly tested viruses include Influenza A (H1N1 and H3N2), Human coronavirus, RSV, Adenovirus, and others. The specific virus strains used will depend on your product’s intended claims and the requirements of your target regulatory agency. Contact our team to discuss the most appropriate organisms for your product.

What is the difference between ASTM E1053 and BS EN 13610?

ASTM E1053 is a US standard primarily used for EPA and FDA submissions, testing virucidal efficacy of surface disinfectants using human-relevant viruses grown in cultured cells. BS EN 13610 is a European standard that uses bacteriophages as surrogate test organisms for food and industrial disinfectant applications. For products targeting both US and European markets, both tests may be required.

Is additional testing required alongside ASTM E1053 for product registration?

Certain regulatory agencies may require additional carrier tests alongside ASTM E1053 for product registration purposes. The exact requirements depends on the target regulatory agency, product type, and claims being made. Airmid’s team can advise on the full testing programme required for your specific regulatory submission.

What will I receive after ASTM E1053 testing?

You will receive a full GLP-compliant test report detailing the methodology, virus strains used, test conditions, virucidal efficacy data, and conclusions — ready for use in EPA submissions, FDA submissions, and marketing claims. The report will meet the GLP documentation requirements of 40 CFR Part 160 and/or 21 CFR Part 58 as applicable.

Related Tests and Services

Submit Your Enquiry

This field is for validation purposes and should be left unchanged.
Contact Name(Required)
Scroll to Top